Skip to main content
Erschienen in: Surgery Today 1/2016

01.01.2016 | Original Article

Limited resections for duodenal gastrointestinal stromal tumors and their oncologic outcomes

verfasst von: Jun Chul Chung, Hyung Chul Kim, Sung Mo Hur

Erschienen in: Surgery Today | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Limited resection is considered a treatment option for duodenal gastrointestinal stromal tumors (GISTs) whenever technically feasible, but the optimal technique for this is still not well defined. We present the various types of limited resections for duodenal GISTs and analyze their postoperative outcomes.

Methods

The subjects of this retrospective clinicopathologic analysis were 21 patients who underwent limited resections for duodenal GIST between May, 2001 and June, 2014. The median follow-up period was 52 months (range 5–125 months).

Results

The patients comprised 12 men and 9 women, with a median age of 59 years (range 45–75 years), all of whom were treated by various forms of limited resection with clear margins. There were ten wedge resections with primary closure (eight open/two laparoscopic), two wedge resections with Roux-en Y duodenojejunostomy, three segmental duodenectomies with end-to-end duodenoduodenostomy, and six segmental duodenectomies with end-to-end duodenojejunostomy. Hepatic metastasis was found 27 months after surgery in one patient, who was given imatinib mesylate for 17 months to slow disease progression. The other 20 patients were alive and recurrence free at the time of writing.

Conclusion

Excellent recurrence-free survival was achieved after limited resections, supporting the consideration of various methods of limited resection as the treatment of choice for duodenal GISTs.
Literatur
1.
Zurück zum Zitat Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.CrossRefPubMed Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol. 2002;33:459–65.CrossRefPubMed
2.
Zurück zum Zitat Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcoma in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27:625–41.CrossRefPubMed Miettinen M, Kopczynski J, Makhlouf HR, Sarlomo-Rikala M, Gyorffy H, Burke A, et al. Gastrointestinal stromal tumors, intramural leiomyomas, and leiomyosarcoma in the duodenum: a clinicopathologic, immunohistochemical, and molecular genetic study of 167 cases. Am J Surg Pathol. 2003;27:625–41.CrossRefPubMed
3.
Zurück zum Zitat Kwon SH, Cha HJ, Jung SW, Kim BC, Park JS, Jeong ID, et al. A gastrointestinal tumor of the duodenum masquerading as a pancreatic head tumor. World J Gastroenterol. 2007;13:3396–9.PubMedCentralCrossRefPubMed Kwon SH, Cha HJ, Jung SW, Kim BC, Park JS, Jeong ID, et al. A gastrointestinal tumor of the duodenum masquerading as a pancreatic head tumor. World J Gastroenterol. 2007;13:3396–9.PubMedCentralCrossRefPubMed
4.
Zurück zum Zitat Butt J, Rowley S, Byrne PJ, Reynolds JV. Management of gastrointestinal stromal tumours: a single-centre experience. Ir J Med Sci. 2007;176:157–60.CrossRefPubMed Butt J, Rowley S, Byrne PJ, Reynolds JV. Management of gastrointestinal stromal tumours: a single-centre experience. Ir J Med Sci. 2007;176:157–60.CrossRefPubMed
5.
Zurück zum Zitat Winfield RD, Hochwald SN, Vogel SB, Hemming AW, Liu C, Cance WG, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum. Am Surg. 2006;72:719–23.PubMed Winfield RD, Hochwald SN, Vogel SB, Hemming AW, Liu C, Cance WG, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum. Am Surg. 2006;72:719–23.PubMed
6.
Zurück zum Zitat Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumors. Br J Surg. 2003;90:1178–86.CrossRefPubMed Connolly EM, Gaffney E, Reynolds JV. Gastrointestinal stromal tumors. Br J Surg. 2003;90:1178–86.CrossRefPubMed
7.
Zurück zum Zitat Goh BK, Chow PK, Kesavan S, Yap WM, Wong WK. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol. 2008;97:388–91.CrossRefPubMed Goh BK, Chow PK, Kesavan S, Yap WM, Wong WK. Outcome after surgical treatment of suspected gastrointestinal stromal tumors involving the duodenum: is limited resection appropriate? J Surg Oncol. 2008;97:388–91.CrossRefPubMed
8.
Zurück zum Zitat Goh BK, Chow PK, Ong HS, Wong WK. Gastrointestinal stromal tumor involving the second and third portion of the duodenum: treatment by partial duodenectomy and Roux-en Y duodenojejunostomy. J Surg Oncol. 2005;91:273–5.CrossRefPubMed Goh BK, Chow PK, Ong HS, Wong WK. Gastrointestinal stromal tumor involving the second and third portion of the duodenum: treatment by partial duodenectomy and Roux-en Y duodenojejunostomy. J Surg Oncol. 2005;91:273–5.CrossRefPubMed
9.
Zurück zum Zitat Chung JC, Kim HC, Chu CW. Segmental duodenectomy with duodenojejunostomy of gastrointestinal stromal tumor involving the duodenum. J Korean Surg Soc. 2011;80:S12–6.PubMedCentralCrossRefPubMed Chung JC, Kim HC, Chu CW. Segmental duodenectomy with duodenojejunostomy of gastrointestinal stromal tumor involving the duodenum. J Korean Surg Soc. 2011;80:S12–6.PubMedCentralCrossRefPubMed
10.
Zurück zum Zitat Hoeppner J, Kulemann B, Marjanovic G, Bronsert P, Hopt UT. Limited resection for duodenal gastrointestinal stromal tumors: surgical management and clinical outcome. World J Gastrointest Surg. 2013;5:16–21.PubMedCentralCrossRefPubMed Hoeppner J, Kulemann B, Marjanovic G, Bronsert P, Hopt UT. Limited resection for duodenal gastrointestinal stromal tumors: surgical management and clinical outcome. World J Gastrointest Surg. 2013;5:16–21.PubMedCentralCrossRefPubMed
11.
Zurück zum Zitat Yamashita S, Sakamoto Y, Saiura A, Yamamoto J, Kosuge T, Aoki T, et al. Pancreas-sparing duodenectomy for gastrointestinal stromal tumor. Am J Surg. 2014;207:578–83.CrossRefPubMed Yamashita S, Sakamoto Y, Saiura A, Yamamoto J, Kosuge T, Aoki T, et al. Pancreas-sparing duodenectomy for gastrointestinal stromal tumor. Am J Surg. 2014;207:578–83.CrossRefPubMed
12.
Zurück zum Zitat Chung JC, Chu CW, Cho GS, Shin EJ, Lim CW, Kim HC, et al. Management and outcome of gastrointestinal stromal tumors of the duodenum. J Gastrointest Surg. 2010;14:880–3.CrossRefPubMed Chung JC, Chu CW, Cho GS, Shin EJ, Lim CW, Kim HC, et al. Management and outcome of gastrointestinal stromal tumors of the duodenum. J Gastrointest Surg. 2010;14:880–3.CrossRefPubMed
13.
Zurück zum Zitat El-Gendi A, El-Gendi S, El-Gendi M. Feasibility and oncologic outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST. J Gastrointest Surg. 2012;16:197–202.CrossRef El-Gendi A, El-Gendi S, El-Gendi M. Feasibility and oncologic outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST. J Gastrointest Surg. 2012;16:197–202.CrossRef
14.
Zurück zum Zitat Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. Ann Surg Oncol. 2012;19:3351–60.CrossRefPubMed Johnston FM, Kneuertz PJ, Cameron JL, Sanford D, Fisher S, Turley R, et al. Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis. Ann Surg Oncol. 2012;19:3351–60.CrossRefPubMed
15.
Zurück zum Zitat Bourgouin S, Emmanuel H, Guiramand J, Barbier L, Delpero JR, Treut YL, et al. Duodenal gastrointestinal stromal tumors (GISTs): arguments for conservative surgery. J Gastrointest Surg. 2013;17:482–7.CrossRefPubMed Bourgouin S, Emmanuel H, Guiramand J, Barbier L, Delpero JR, Treut YL, et al. Duodenal gastrointestinal stromal tumors (GISTs): arguments for conservative surgery. J Gastrointest Surg. 2013;17:482–7.CrossRefPubMed
16.
Zurück zum Zitat Chok AY, Koh YX, Ow MY, Allen JC Jr, Goh BK. A systemic review and meta-analysis comparing pancreaticoduodenectomy versus limited resection for duodenal gastrointestinal stromal tumors. Ann Surg Oncol. 2014;21:3429–38.CrossRefPubMed Chok AY, Koh YX, Ow MY, Allen JC Jr, Goh BK. A systemic review and meta-analysis comparing pancreaticoduodenectomy versus limited resection for duodenal gastrointestinal stromal tumors. Ann Surg Oncol. 2014;21:3429–38.CrossRefPubMed
17.
Zurück zum Zitat Yildirgan MI, Başoglu M, Atamanalp SS, Albayrak Y, Gürsan N, Onbaş O. Duodenal stromal tumor: report of case. Surg Today. 2007;37:426–9.CrossRefPubMed Yildirgan MI, Başoglu M, Atamanalp SS, Albayrak Y, Gürsan N, Onbaş O. Duodenal stromal tumor: report of case. Surg Today. 2007;37:426–9.CrossRefPubMed
18.
Zurück zum Zitat Yang F, Jin C, Du Z, Subedi S, Jiang Y, Li J, et al. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes. Am J Surg. 2013;206:360–7.CrossRefPubMed Yang F, Jin C, Du Z, Subedi S, Jiang Y, Li J, et al. Duodenal gastrointestinal stromal tumor: clinicopathological characteristics, surgical outcomes, long term survival and predictors for adverse outcomes. Am J Surg. 2013;206:360–7.CrossRefPubMed
19.
Zurück zum Zitat Pratt WB, Maithel SK, Vanounou T, Huang ZS, Callery MP, Vollmer CM Jr. Clinical and economic validation of the international study group of pancreatic fistula (ISGPF) classification scheme. Ann Surg. 2007;245:443–51.PubMedCentralCrossRefPubMed Pratt WB, Maithel SK, Vanounou T, Huang ZS, Callery MP, Vollmer CM Jr. Clinical and economic validation of the international study group of pancreatic fistula (ISGPF) classification scheme. Ann Surg. 2007;245:443–51.PubMedCentralCrossRefPubMed
20.
Zurück zum Zitat Uchida H, Sasaki A, Iwaki K, Tominaga M, Yada K, Iwashita Y, et al. An extramural gastrointestinal stromal tumor of the duodenum mimicking a pancreatic head tumor. J Hepatobiliary Pancreat Surg. 2005;12:324–7.CrossRefPubMed Uchida H, Sasaki A, Iwaki K, Tominaga M, Yada K, Iwashita Y, et al. An extramural gastrointestinal stromal tumor of the duodenum mimicking a pancreatic head tumor. J Hepatobiliary Pancreat Surg. 2005;12:324–7.CrossRefPubMed
21.
Zurück zum Zitat Yoshikawa K, Shimada M, Kurita N, Sato H, Iwata T, Morimoto S, et al. The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors. Surg Today. 2013;43:1162–7.CrossRefPubMed Yoshikawa K, Shimada M, Kurita N, Sato H, Iwata T, Morimoto S, et al. The efficacy of PET-CT for predicting the malignant potential of gastrointestinal stromal tumors. Surg Today. 2013;43:1162–7.CrossRefPubMed
22.
Zurück zum Zitat Lau S, Tam KF, Kam CK, Lui CY, Siu CW, Lam HS, et al. Imaging of gastrointestinal stromal tumour (GIST). Clin Radiol. 2004;59:487–98.CrossRefPubMed Lau S, Tam KF, Kam CK, Lui CY, Siu CW, Lam HS, et al. Imaging of gastrointestinal stromal tumour (GIST). Clin Radiol. 2004;59:487–98.CrossRefPubMed
23.
Zurück zum Zitat Takahashi Y, Noguchi T, Takeno S, Uchida Y, Shimoda H, Yokoyama S. Gastrointestinal tumor of the duodenal ampulla: report of a case. Surg Today. 2001;31:722–6.CrossRefPubMed Takahashi Y, Noguchi T, Takeno S, Uchida Y, Shimoda H, Yokoyama S. Gastrointestinal tumor of the duodenal ampulla: report of a case. Surg Today. 2001;31:722–6.CrossRefPubMed
24.
Zurück zum Zitat Sasaki A, Nitta H, Otsuka K, Fujiwara H, Takahara T, Wakabayashi G. Single-port versus multiport laparoscopic resection for gastric gastrointestinal stromal tumors: a case-matched comparison. Surg Today. 2014;44:1282–6.CrossRefPubMed Sasaki A, Nitta H, Otsuka K, Fujiwara H, Takahara T, Wakabayashi G. Single-port versus multiport laparoscopic resection for gastric gastrointestinal stromal tumors: a case-matched comparison. Surg Today. 2014;44:1282–6.CrossRefPubMed
25.
Zurück zum Zitat Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:1097–104.PubMedCentralCrossRefPubMed Dematteo RP, Ballman KV, Antonescu CR, Maki RG, Pisters PW, Demetri GD, et al. Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;373:1097–104.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307:1265–72.CrossRefPubMed Joensuu H, Eriksson M, Sundby Hall K, Hartmann JT, Pink D, Schütte J, et al. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial. JAMA. 2012;307:1265–72.CrossRefPubMed
27.
Zurück zum Zitat van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer. 2005;104:1781–8.CrossRefPubMed van der Zwan SM, DeMatteo RP. Gastrointestinal stromal tumor: 5 years later. Cancer. 2005;104:1781–8.CrossRefPubMed
28.
Zurück zum Zitat Demetri GD, von Mehren M, Blanke CD, van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–80.CrossRefPubMed Demetri GD, von Mehren M, Blanke CD, van den Abbeele AD, Eisenberg B, Roberts PJ, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med. 2002;347:472–80.CrossRefPubMed
29.
Zurück zum Zitat Loughrey MB, Mitchell C, Mann GB, Michael M, Waring PM. Gastrointestinal stromal tumour treated with neoadjuvant imatinib. J Clin Pathol. 2005;58:779–81.PubMedCentralCrossRefPubMed Loughrey MB, Mitchell C, Mann GB, Michael M, Waring PM. Gastrointestinal stromal tumour treated with neoadjuvant imatinib. J Clin Pathol. 2005;58:779–81.PubMedCentralCrossRefPubMed
30.
Zurück zum Zitat Ludvigsen L, Toxverd A, Mahdi B, Krarup-hansen A, Bergenfeldt M. Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case. Surg Today. 2007;37:1105–9.CrossRefPubMed Ludvigsen L, Toxverd A, Mahdi B, Krarup-hansen A, Bergenfeldt M. Successful resection of an advanced duodenal gastrointestinal stromal tumor after down-staging with imatinib: report of a case. Surg Today. 2007;37:1105–9.CrossRefPubMed
31.
Zurück zum Zitat Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2004;11:465–75.CrossRefPubMed Eisenberg BL, Judson I. Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy. Ann Surg Oncol. 2004;11:465–75.CrossRefPubMed
Metadaten
Titel
Limited resections for duodenal gastrointestinal stromal tumors and their oncologic outcomes
verfasst von
Jun Chul Chung
Hyung Chul Kim
Sung Mo Hur
Publikationsdatum
01.01.2016
Verlag
Springer Japan
Erschienen in
Surgery Today / Ausgabe 1/2016
Print ISSN: 0941-1291
Elektronische ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1163-x

Weitere Artikel der Ausgabe 1/2016

Surgery Today 1/2016 Zur Ausgabe

Leitlinien kompakt für die Allgemeinmedizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Facharzt-Training Allgemeinmedizin

Die ideale Vorbereitung zur anstehenden Prüfung mit den ersten 24 von 100 klinischen Fallbeispielen verschiedener Themenfelder

Mehr erfahren

Update Allgemeinmedizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.